IL-2 antibodies in type 1 diabetes and during IL-2 therapy

Guillaume Churlaud, Michelle Rosenzwajg, Patrice Cacoub, David Saadoun, Dominique Valteau-Couanet, Nathalie Chaput, Alberto Pugliese, David Klatzmann

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)1-3
Number of pages3
JournalDiabetologia
DOIs
StateAccepted/In press - Jun 2 2018

Fingerprint

Type 1 Diabetes Mellitus
Interleukin-2
Antibodies
Therapeutics

Keywords

  • Autoantibodies
  • Autoimmune disease
  • Autoimmunity
  • IL-2
  • Type 1 diabetes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Churlaud, G., Rosenzwajg, M., Cacoub, P., Saadoun, D., Valteau-Couanet, D., Chaput, N., ... Klatzmann, D. (Accepted/In press). IL-2 antibodies in type 1 diabetes and during IL-2 therapy. Diabetologia, 1-3. https://doi.org/10.1007/s00125-018-4649-4

IL-2 antibodies in type 1 diabetes and during IL-2 therapy. / Churlaud, Guillaume; Rosenzwajg, Michelle; Cacoub, Patrice; Saadoun, David; Valteau-Couanet, Dominique; Chaput, Nathalie; Pugliese, Alberto; Klatzmann, David.

In: Diabetologia, 02.06.2018, p. 1-3.

Research output: Contribution to journalArticle

Churlaud, G, Rosenzwajg, M, Cacoub, P, Saadoun, D, Valteau-Couanet, D, Chaput, N, Pugliese, A & Klatzmann, D 2018, 'IL-2 antibodies in type 1 diabetes and during IL-2 therapy', Diabetologia, pp. 1-3. https://doi.org/10.1007/s00125-018-4649-4
Churlaud G, Rosenzwajg M, Cacoub P, Saadoun D, Valteau-Couanet D, Chaput N et al. IL-2 antibodies in type 1 diabetes and during IL-2 therapy. Diabetologia. 2018 Jun 2;1-3. https://doi.org/10.1007/s00125-018-4649-4
Churlaud, Guillaume ; Rosenzwajg, Michelle ; Cacoub, Patrice ; Saadoun, David ; Valteau-Couanet, Dominique ; Chaput, Nathalie ; Pugliese, Alberto ; Klatzmann, David. / IL-2 antibodies in type 1 diabetes and during IL-2 therapy. In: Diabetologia. 2018 ; pp. 1-3.
@article{42e2ab05179b4e7eaf879cbe5b09b5ed,
title = "IL-2 antibodies in type 1 diabetes and during IL-2 therapy",
keywords = "Autoantibodies, Autoimmune disease, Autoimmunity, IL-2, Type 1 diabetes",
author = "Guillaume Churlaud and Michelle Rosenzwajg and Patrice Cacoub and David Saadoun and Dominique Valteau-Couanet and Nathalie Chaput and Alberto Pugliese and David Klatzmann",
year = "2018",
month = "6",
day = "2",
doi = "10.1007/s00125-018-4649-4",
language = "English (US)",
pages = "1--3",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - IL-2 antibodies in type 1 diabetes and during IL-2 therapy

AU - Churlaud, Guillaume

AU - Rosenzwajg, Michelle

AU - Cacoub, Patrice

AU - Saadoun, David

AU - Valteau-Couanet, Dominique

AU - Chaput, Nathalie

AU - Pugliese, Alberto

AU - Klatzmann, David

PY - 2018/6/2

Y1 - 2018/6/2

KW - Autoantibodies

KW - Autoimmune disease

KW - Autoimmunity

KW - IL-2

KW - Type 1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85047911511&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047911511&partnerID=8YFLogxK

U2 - 10.1007/s00125-018-4649-4

DO - 10.1007/s00125-018-4649-4

M3 - Article

C2 - 29860627

AN - SCOPUS:85047911511

SP - 1

EP - 3

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

ER -